Search

In Stock

Buy Zokinvy (lonafarnib) Online

DISEASE INDICATIONS: Progeria

MANUFACTURER: Eiger Biopharmaceuticals

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Zokinvy (lonafarnib) is a prescription medication used to treat Hutchinson-Gilford progeria syndrome (HGPS) and processing-deficient progeroid laminopathies (PDPL) in children aged 12 months and older. HGPS and PDPL are rare genetic disorders that cause premature aging.

From $31,401.66

Clear
Compare

Zokinvy (lonafarnib) is a prescription medication used to treat Hutchinson-Gilford progeria syndrome (HGPS) and processing-deficient progeroid laminopathies (PDPL) in children aged 12 months and older. HGPS and PDPL are rare genetic disorders that cause premature aging.

Zokinvy is a farnesyltransferase inhibitor (FTI), which is a type of drug that blocks the activity of an enzyme called farnesyltransferase. Farnesyltransferase is an enzyme that plays a role in the production of a protein called progerin. Progerin is a defective protein that accumulates in the cells of people with HGPS and PDPL, and it is thought to be responsible for the premature aging symptoms of these diseases.

Zokinvy is given as a capsule twice daily with food. The dose is based on the patient’s height and weight.

How effective is Zokinvy?

In clinical studies, Zokinvy was shown to improve the quality of life and prolong the lifespan of children with HGPS and PDPL. In one study, children treated with Zokinvy had a median survival of 14.5 years, compared to a median survival of 8.2 years in children who received a placebo.

What are the side effects of Zokinvy?

The most common side effects of Zokinvy are:

  • Nausea
  • Vomiting
  • Diarrhea
  • Fatigue
  • Headache
  • Abdominal pain
  • Decreased appetite
  • Constipation
  • Weight loss

Zokinvy can also cause more serious side effects, such as:

  • Liver problems
  • Kidney problems
  • Allergic reactions
  • Bone marrow suppression

Who should not take Zokinvy?

Zokinvy should not be taken by people who are allergic to lonafarnib or any of the other ingredients in Zokinvy. It should also not be taken by people with:

  • Severe liver disease
  • Severe kidney disease
  • Pregnancy
  • Breastfeeding

Important safety information

It is important to tell your doctor about all of the medications you are taking before starting Zokinvy. Zokinvy can interact with other drugs, such as certain antibiotics and anticonvulsants.

Zokinvy should be used with caution in people with liver disease, kidney disease, and diabetes.

Zokinvy can cause serious side effects, such as liver problems and kidney problems. It is important to monitor your liver and kidney function regularly while taking Zokinvy.

If you are considering taking Zokinvy, talk to your doctor about the risks and benefits of the medication.

Package

30 capsules of 50 mg, 30 capsules of 75 mg

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Zegalogue (dasiglucagon) Online

From $312.85
(0 Reviews)
DISEASE INDICATIONS: Diabetes MANUFACTURER: Zeeland Pharma USAGE: Subcutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Zegalogue (dasiglucagon) is a prescription medication used to treat severe hypoglycemia (very low blood sugar) in adults and children with diabetes aged 6 years and older.

Buy Roszet (rosuvastatin and ezetimibe) Online

(0 Reviews)
DISEASE INDICATIONS: Hypercholesterolemia MANUFACTURER: Althera Life Sciences USAGE: Oral MEDICINE APPROVED BY: Food and Drug Administration (FDA) Roszet (rosuvastatin and ezetimibe) is a combination medication used to lower cholesterol levels in the blood. It is a combination of two different medications: rosuvastatin, a statin, and ezetimibe, a cholesterol absorption inhibitor.

Buy Crysvita (burosumab) Online

From $3,328.84
(0 Reviews)
Crysvita (burosumab) is a human monoclonal antibody medication used to treat X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO) in adults and children 6 months of age and older. It is the first and only FDA-approved treatment for XLH.

Buy Voxzogo (vosoritide) Online

$9,091.90
(0 Reviews)
DISEASE INDICATIONS: Achondroplasia MANUFACTURER: BioMarin Europe Ltd USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Voxzogo (vosoritide) is a prescription medicine used to increase linear growth in children with achondroplasia aged 5 years and older with open growth plates. Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth.

Buy Palynziq (pegvaliase-pqpz) Online

From $321.42
(0 Reviews)
DISEASE INDICATIONS: phenylketonuria (PKU) MANUFACTURER: BioMarin Pharmaceutical Inc. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Palynziq (pegvaliase-pqpz) is a prescription medication used to lower blood levels of phenylalanine (Phe) in adults with phenylketonuria (PKU) who have uncontrolled blood Phe levels above 600 micromol/L (10 mg/dL) on their current treatment. PKU is a rare genetic disorder that prevents the body from breaking down the amino acid phenylalanine. Phenylalanine can build up in the blood and cause serious health problems, such as intellectual disability, seizures, and behavioral problems.

Buy Waylivra (volanesorsen) Online

$11,550.76
(0 Reviews)
DISEASE INDICATIONS: Familial chylomicronemia syndrome (FCS) MANUFACTURER: Akcea Therapeutics Ireland Limited USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Waylivra (volanesorsen) is a prescription medication used to treat adults with genetically confirmed familial chylomicronemia syndrome (FCS) and at high risk for pancreatitis, in whom response to diet and triglyceride lowering therapy has been inadequate. FCS is a rare genetic disorder that causes the body to produce too much of a type of fat called chylomicrons. Chylomicrons can build up in the blood and cause pancreatitis, a serious inflammation of the pancreas.

Buy Isturisa (osilodrostat) Online

From $1,818.17
(0 Reviews)
DISEASE INDICATIONS: Primary Biliary Cholangitis (PBC) MANUFACTURER: Novartis USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Isturisa (osilodrostat) is a cortisol synthesis inhibitor used to treat Cushing's syndrome, a condition in which the body produces too much of the hormone cortisol. It is approved by the US Food and Drug Administration (FDA) for adults with Cushing's disease, a type of Cushing's syndrome caused by a tumor on the pituitary gland, and for adults with endogenous Cushing's syndrome (ECS), a type of Cushing's syndrome caused by the body overproducing cortisol on its own.

Back to Top
Product has been added to your cart